Biolistic Delivery of MOF-Protected Liposomes

11 August 2022, Version 1


Needle-and-syringe-based delivery has been the commercial standard for vaccine administration to date. With worsening medical personnel availability, increasing biohazard waste production, and the possibility of cross-contamination, we explore the possibility of biolistic delivery as an alternate skin-based delivery route. Delicate formulations like liposomes are inherently unsuitable for this delivery model as they are delicate biomaterials incapable of withstanding shear stress. When encapsulated within a crystalline and rigid coating made of zeolitic imidazolate frameworks, the liposomes are not only protected from thermal stress but also shear stress. The protection from shear stress is crucial, especially for formulations with cargo encapsulated inside the lumen of the liposomes. Moreover, the coating provides the liposomes a solid, rigid exterior which allows the particles to penetrate the tissue model and porcine tissue effectively.


Supplementary weblinks

Research Group Website
The Gassensmith Group's website where you can find additional publications


Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.